Abstract
Background: Malignant melanoma (MM) is often reported as the third most common cause of intracranial metastasis (IM) after carcinoma of the breast and lung. Most patients with advanced MM will have widespread extracranial disease, but the majority will die from intracerebral spread.
Methods: A retrospective review of 117 patients with documented IM from MM over the past 25 years was undertaken. Various factors (including age, race, sex distribution, primary lesions with Clark's level, Breslow's thickness, primary sites and staging at initial presentation, diagnosis of IM and its various treatment methods, survival data, and autopsy findings) were analyzed. Prognostic indicators were clarified from this analysis as a predictor of central nervous system (CNS) metastasis. An ideal treatment plan was also analyzed in order to predict a better survival.
Results: Fifty-eight percent of patients were male; 42% were female. Seventy-one percent of the primary lesions were of Clark's level IV and V, with mean Breslow's thickness of 3.5 mm. Median time interval between the initial diagnosis and development of IM was 3.5 years. Complete surgical resection of the intracranial lesion in the brain resulted in the longest mean survival of 10.3 months, whereas mean survival for the group with no treatment was only 3 weeks. Patients with primary lesions of the head and neck had the lowest mean survival of 3.3 months, whereas those whose primary sites were unknown had the longest mean survival of 7.5 months. One- and 2-year survival were 9% and 3%, respectively. All but one of the 30 patients at autopsy were found to have visceral metastasis, namely of the lung, liver, and bone.
Conclusion: An aggressive search for metastasis should be undertaken in patients at high risk of developing CNS metastasis, e.g., male, head and neck primary, Clark's level IV and V, Breslow's thickness of >3 mm, and presence of visceral metastases, mainly lung. A complete surgical resection should be attempted whenever possible, with adjunctive use of whole-brain irradiation, along with systemic chemotherapy for further control of recurrence and to prolong survival.
Similar content being viewed by others
References
Muit C, Waterhouse J, Mack T, Powell J, Whelan S, eds.Cancer incidence in five continents. Vol V. Lyons, France: IARC Scientific, 1987.
Boring CC, Squires TS. Cancer statistics, 1991.CA 1991;42:1.
Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival.Cancer 1978;42:660–8.
Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma.Neurosurgery 1981;8:26–30.
Allan SG, Cornbleet MA. Brain metastases in melanoma. In: Rumke P, ed.Therapy of advanced melanoma. Pigment cell. Vol 10. Basel, Switzerland: Karger, 1990:36–52.
Stevens G, Firth I, Coates A. Cerebral metastases from malignant melanoma.Radiother Oncol 1992;23:185–91.
Mendez IM, Del Maestro RF. Cerebral metastases from malignant melanoma.Can J Neurol Sci 1988;15:119–23.
Boddie AW. Three unresolved isues in the surgical treatment of melanoma.Oncology 1988;11:39–50.
Balch CM, Houghton AN. Diagnosis of metastatic melanoma at distant sites. In: Balch CM, Houghton AN, Milton GW, et al., eds.Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992:439–67.
Ginaldi S, Wallace S, Shalen P, Luna M, Handel S. Cranial computed tomography of malignant melanoma.Am J Radiol 1981;136:145–9.
Choi KN, Withers HR, Rotman M. Intracranial metastasis from melanoma.Cancer 1985;56:1–9.
Retsas S, Gershuny AR. Central nervous system involvement in malignant melanoma.Cancer 1988;61:1926–34.
Madajewiez S, Karakousis C, West CR, Caracandas J, Avellanosa AM. Malignant melanoma brain metastasis.Cancer 1984;53:2550–2.
Lashford L, Davies A, Richardson R, et al. A pilot study of 131-I-labelled monoclonal antibodies in the therapy of leptomeningeal disease.Cancer 1988;61:857–68.
Parkinson DR, Houghton AN, Hersey P, Borden EC. Biologic therapy for melanoma. In: Balch CM, Houghton AN, Milton GW, et al., eds.Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992:522–41.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saha, S., Meyer, M., Krementz, E.T. et al. Prognostic evaluation of intracranial metastasis in malignant melanoma. Annals of Surgical Oncology 1, 38–44 (1994). https://doi.org/10.1007/BF02303539
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303539